Cancer Care Now Runs on Data Infrastructure
Why the Future of Oncology Depends on More Than Medicine By David Hutchful When most people think about advances in cancer care, they think about new drugs, new therapies, or breakthrough discoveries in biology. But increasingly, one of the most important determinants of progress in oncology is something far less visible: data infrastructure. Modern cancer […]
African Genomics on the Global Stage: AACR 2026
This year, Yemaachi Biotech was proud to participate in the American Association for Cancer Research (AACR) Annual Meeting in San Diego, one of the world’s largest and most influential cancer research conferences. AACR brings together leading researchers, clinicians, pharmaceutical companies, biotechnology innovators, and policymakers from across the globe to share breakthroughs that are shaping the […]
Early lessons from the implementation of a pan-African clinico-genomic cancer platform: The African Cancer Atlas
Abstract Background: Limited representation of African populations in cancer genomics constrains the clinical applicability of precision oncology. We describe the establishment and early outcomes of The African Cancer Atlas (TACA), a multi-site platform integrating genomics, harmonized clinical data, and community engagement for adult breast cancer research across Africa. Methods: TACA, led by Yemaachi Biotech, has so far […]
Determinants of triple‑negative breast cancer among African patients: Early results from The African Cancer Atlas
Abstract Background: Triple‑negative breast cancer (TNBC) is disproportionately common among women of African ancestry and is associated with aggressive clinical behavior and limited therapeutic options. Understanding demographic and contextual determinants of TNBC across African countries is essential to improving prevention, early detection, and precision oncology strategies. Using harmonized data from The African Cancer Atlas (TACA)–an […]